Vaccine maker BioNTech sees profits soar in second quarter

The Pfizer-BioNTech vaccine (Victoria Jones/PA)

German pharmaceutical maker BioNTech, which developed the first widely used coronavirus vaccine with Pfizer, has seen its profits surge in the second quarter of 2021.

The Mainz-based company said it made a net profit of almost 2.8 billion euros (£2 billion) from April to June.